These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30365902)

  • 1. Use of synthetic and biologic DMARDs during pregnancy.
    Balbi GGM; Domingues V; Balbi GGM; De Jesús GR; Levy RA
    Expert Rev Clin Immunol; 2019 Jan; 15(1):27-39. PubMed ID: 30365902
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers.
    Shimada H; Kameda T; Kanenishi K; Miyatake N; Nakashima S; Wakiya R; Kato M; Miyagi T; Mansour MMF; Hata T; Kadowaki N; Dobashi H
    Clin Rheumatol; 2019 May; 38(5):1453-1458. PubMed ID: 30729372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation.
    Ngian GS; Briggs AM; Ackerman IN; Van Doornum S
    Int J Rheum Dis; 2016 Sep; 19(9):834-43. PubMed ID: 27125255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases.
    N MS; Álvarez-Troncoso J; Robles-Marhuenda Á; De la Calle Fernández-Miranda M; Muner Hernando ML; Bartha JL
    J Autoimmun; 2024 Sep; 148():103301. PubMed ID: 39141986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management.
    Giles I; Thorne I; Schmidt NS; Reid C; Crossley A; Panca M; Freemantle N; Tower C; Dass S; Sharma SK; Williams D; O'Neill S; Dolhain RJEM; Toplak N; Hodson K; Nelson-Piercy C; Clowse MEB
    Lancet Rheumatol; 2024 Aug; 6(8):e546-e559. PubMed ID: 38876126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy.
    Nguyen H; Ahmed K; Luo W; Flint J; Giles I
    Semin Arthritis Rheum; 2021 Dec; 51(6):1205-1217. PubMed ID: 34689007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception and pregnancy counselling in rheumatoid arthritis.
    Østensen M
    Curr Opin Rheumatol; 2014 May; 26(3):302-7. PubMed ID: 24663105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infectious complications of biologic therapy in patients with rheumatoid arthritis].
    Meyer-Olson D; Hoeper K; Schmidt RE
    Z Rheumatol; 2010 Dec; 69(10):879-88. PubMed ID: 21128049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.
    Flint J; Panchal S; Hurrell A; van de Venne M; Gayed M; Schreiber K; Arthanari S; Cunningham J; Flanders L; Moore L; Crossley A; Purushotham N; Desai A; Piper M; Nisar M; Khamashta M; Williams D; Gordon C; Giles I;
    Rheumatology (Oxford); 2016 Sep; 55(9):1693-7. PubMed ID: 26750124
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapies and pregnancy: the story so far.
    Hyrich KL; Verstappen SM
    Rheumatology (Oxford); 2014 Aug; 53(8):1377-85. PubMed ID: 24352337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
    Levesque MC
    BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.
    Williams M; Chakravarty EF
    Curr Opin Rheumatol; 2014 May; 26(3):341-6. PubMed ID: 24663107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies.
    Singh JA
    Curr Rheumatol Rep; 2016 Oct; 18(10):61. PubMed ID: 27613285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy use and pregnancy outcomes in women with immune-mediated inflammatory rheumatic diseases.
    Brites L; Madeira N; Rodrigues J; Marona J; Martins N; Águeda A; Freitas R; Neto A; Capela S; Sequeira G; Ganhão S; Duarte C; Santiago M; Santos MJ
    Acta Reumatol Port; 2019; 44(4):266-272. PubMed ID: 32008032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.
    Abasolo L; Leon L; Rodriguez-Rodriguez L; Tobias A; Rosales Z; Maria Leal J; Castaño V; Vadillo C; Macarron P; Fontsere O; Jover JA
    Semin Arthritis Rheum; 2015 Apr; 44(5):506-513. PubMed ID: 25532946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.